DSC: Exploring the Safety and Efficacy of Everolimus in PTEN Hamartoma Tumor Syndrome

Nov 7, 2022 · 2m 1s
DSC: Exploring the Safety and Efficacy of Everolimus in PTEN Hamartoma Tumor Syndrome
Description

New research from the Developmental Synaptopathies Consortium (DSC). This summary is based on a paper published in the journal Human Molecular Genetics on October 15, 2022, titled "A randomized controlled...

show more
New research from the Developmental Synaptopathies Consortium (DSC). This summary is based on a paper published in the journal Human Molecular Genetics on October 15, 2022, titled "A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndrome."

Read the paper here: https://academic.oup.com/hmg/article/31/20/3393/6589680

Learn more about DSC: https://www1.rarediseasesnetwork.org/cms/dsc
show less
Information
Author RDCRN
Organization RDCRN
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search